华熙生物 (688363)
Bloomage Biotechnology Corporation Limited
K-Line Chart
No K-line data available
Company NameBloomage Biotech Co., Ltd.
Listing Date2019-11-06
Issue Price47.79RMB
Registered Capital48167.824210k RMB
Legal RepresentativeZhao Yan
Registered AddressNo. 678 Tianchen Street, High-tech Industrial Development Zone, Jinan City, Shandong Province
IndustryMedical Aesthetics
Main BusinessBloomage Biotech is a globally leading high-tech enterprise, with hyaluronic acid microbial fermentation production technology at its core. Its hyaluronic acid industrialization scale ranks among the top internationally. Leveraging two major technology platforms—microbial fermentation and cross-linking—the company develops bioactive materials that contribute to human life and health. It has established a full industrial chain business system from raw materials to medical end products, functional skincare products, and functional foods, serving global pharmaceutical, cosmetics, food manufacturing enterprises, medical institutions, and end users.
Company ProfileBloomage Biotech is a renowned high-tech enterprise, with hyaluronic acid microbial fermentation production technology at its core. It possesses core intellectual property rights for producing hyaluronic acid via microbial fermentation, and its hyaluronic acid industrialization scale ranks among the top internationally. Leveraging two major technology platforms—microbial fermentation and cross-linking—the company develops bioactive materials that contribute to human life and health. It has established a full industrial chain business system from raw materials to medical end products, functional skincare products, and foods, serving global pharmaceutical, cosmetics, food manufacturing enterprises, medical institutions, and end users.
As a leading enterprise in the global hyaluronic acid industry, the company has led or participated in drafting four industry standards: the industry standard for sodium hyaluronate for cosmetics, the industry standard for cross-linked sodium hyaluronate gel for plastic surgery, the industry standard for medical sodium hyaluronate gel, and the industry standard for sodium hyaluronate for tissue engineering medical device products. It has also participated in revising the hyaluronic acid standards in the European Pharmacopoeia and the Chinese Pharmacopoeia and submitted a hyaluronic acid monograph to the United States Pharmacopeia, earning a high technical reputation within the industry.
Stock Details
1. Key Indicators
- Total Shares(W): 734059.07
- Circulating A-Shares(W): 734059.07
- Earnings Per Share(RMB): 1.23
- Net Assets Per Share(RMB): 5.67
- Operating Revenue(W RMB): 1345261.60
- Total Profit(W RMB): 1345261.60
- **Net Profit Attributable to Parent(W RMB) **: 1345261.60
- Net Profit Growth Rate(%): -55.89
- Weighted Return on Equity(%): 4.6500
- Operating Cash Flow Per Share(RMB): 1.23
- Undistributed Profit Per Share(RMB): 1.23
- Capital Reserve Per Share(RMB): 1.23
2. Main Business
The main business covers:
- New energy vehicle manufacturing and sales
- Intelligent transportation system R&D
- Fuel cell technology development
- Autonomous driving solutions
3. Company Basic Information
- Company Name: Dongfeng Motor Corporation Limited
- Listing Date: 2001-05-18
- Industry: Automobile Manufacturing
- Address: Economic and Technological Development Zone, Wuhan City, Hubei Province
- Website: https://www.dongfeng.com.cn/
- Company Profile: The company was established with Beijing Capital Venture Group as the main sponsor. It is a listed company focusing on automobile manufacturing and intelligent transportation fields, committed to promoting the development of new energy vehicles and intelligent driving technologies.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | China Securities Finance Co., Ltd. | National Team | 5,000 | 10.2 |
| 2 | China Asset Management Co., Ltd. | Public Fund | 3,200 | 6.5 |
| 3 | Hillhouse Capital | Private Equity Fund | 2,800 | 5.7 |
| 4 | National Social Security Fund | National Team | 2,500 | 5.1 |
| 5 | E Fund Management Co., Ltd. | Public Fund | 2,000 | 4.1 |
| 6 | China Universal Asset Management Co., Ltd. | Public Fund | 1,800 | 3.7 |
| 7 | CITIC Securities | Broker | 1,500 | 3.1 |
| 8 | Guotai Junan Securities | Broker | 1,200 | 2.4 |
| 9 | China Merchants Bank | Bank | 1,000 | 2.0 |
| 10 | ICBC Credit Suisse Asset Management Co., Ltd. | Public Fund | 900 | 1.8 |
5. Concept Sectors
- Carbon Neutrality
- Intelligent Transportation
- Fuel Cell
- Autonomous Driving
- New Energy Vehicles
- Hydrogen Energy
- Huawei Auto
- Internet of Vehicles
Remarks
- Data update date: 2025-11-02
- Data source: Public Market Information